Furthermore, TLE1 expression was associated with better prognosis in gastric cancer and human epidermal growth-factor receptor 2 (HER2)-positive or triple-negative breast cancer, and the clinical significance of the expression profile of TLE1 in several carcinomas was recently reported [11, 14]. Here, ERBB2 is linked to gastric cancer.